See all
 |
Articles: Atherosclerosis/Lipids |
Prior Articles
Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk
Vascular Health and Risk Management, 09/22/09
Free full text
Noninvasive Assessment of Atherosclerosis in Patients with Isolated Hypertension
Echocardiography, 09/22/09 Synergistic Effects of Elevated Systolic Blood Pressure and Hypercholesterolemia on Carotid Intima–Media Thickness in Children and Adolescents
Pediatric Cardiology, 09/22/09 Inhibition of Prolyl Hydroxylase Domain-Containing Protein Suppressed Lipopolysaccharide-Induced TNF-alpha Expression
Arteriosclerosis, Thrombosis, and Vascular Biology, 09/22/09 Periadventitial Adipose Tissue Plays a Critical Role in Vascular Remodeling
Circulation Research, 09/22/09 Shear Stress Regulates Angiotensin Type 1 Receptor Expression in Endothelial Cells
Circulation Research, 09/22/09 At Sea with SEAS: The First Clinical Endpoint Trial for Ezetimibe, Treatment of Patients with Mild to Moderate Aortic Stenosis, Ends with Mixed Results and More Controversy
Heart, Lung, and Circulation, 09/21/09 PCSK9 Dominant Negative Mutant Results in Increased LDL Catabolic Rate and Familial Hypobetalipoproteinemia
Arteriosclerosis, Thrombosis, and Vascular Biology, 09/21/09 Atherosclerosis profile and incidence of cardiovascular events: a population-based survey
BMC Cardiovascular Disorders, 09/18/09 Absence of Akt1 Reduces Vascular Smooth Muscle Cell Migration and Survival and Induces Features of Plaque Vulnerability and Cardiac Dysfunction During Atherosclerosis
Arteriosclerosis, Thrombosis, and Vascular Biology, 09/18/09 Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events
JACC - Journal of the American College of Cardiology: Cardiovascular Imaging, 09/18/09 Preexcitation syndromes: diagnostic consideration in the ED
The American Journal of Emergency Medicine, 09/18/09 Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic
Expert Opinion on Investigational Drugs, 09/18/09 Novel Lipids Targets in the Era of Metabolic Syndrome: Toward a Better Prediction of Cardiovascular Risk
High Blood Pressure & Cardiovascular Prevention, 09/18/09 HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity. Relevance to Inflammation and Atherogenesis
Arteriosclerosis, Thrombosis, and Vascular Biology, 09/18/09 Local lipopolysaccharide injection: A potential novel treatment for heterotopic ossification
Medical Hypotheses, 09/18/09 Cost effectiveness and screening interval of lipid screening in Hodgkins lymphoma survivors
Journal of Clinical Oncology, 09/17/09 Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome
JAMA, 09/17/09 Normal weight obesity: Relationship with lipids, glycaemic status, liver enzymes and inflammation
Nutrition, Metabolism & Cardiovascular Diseases, 09/17/09 The good and the bad: what researchers have learned about dietary cholesterol, lipid management and cardiovascular disease risk since the Harvard Egg Study
International Journal of Clinical Practice, 09/17/09
Revew Article
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: American Heart Journal, American Journal of Cardiology, Circulationn, Heart
more...
|
250 Available Pages
|
|